Key facts
- Asima Health’s last known valuation is $5.0M (Dec 2024).
- It has raised $4.3M; the latest was Seed Round ($2.0M) in Feb 2026.
- Notable investors include Plug and Play Tech Center, Creative Destruction Lab, University of Toronto, i.d.e.a. Fund, Connection Silicon Valley — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Asima Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Asima Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Asima Health
Developer of a lab-on-a-chip molecular diagnostic platform intended to enable early, rapid, and low-cost cancer monitoring. The company offers a multi-cancer blood-based testing technology with same-day results, detection of primary and secondary cancers from a single blood draw, and a benchtop system for decentralized testing, enabling local laboratories and oncology care providers to conduct frequent high-complexity cancer diagnostics with improved patient monitoring and reduced reliance on centralized facilities.
- Sector
- Healthcare
- HQ
- Kitchener, Canada
- Founded
- 2023
- Employees
- 3
- Website
- asimahealth.com/
- Ownership
- Privately Held (backing)
Asima Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Asima Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Asima Health in its N-PORT filings yet. We sweep new filings monthly.